
Danaher Corporation DHR
$ 189.77
-0.12%
Annual report 2025
added 02-24-2026
Danaher Corporation EV - Enterprise Value 2011-2026 | DHR
Annual EV - Enterprise Value Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 B | 150 B | 177 B | 175 B | 193 B | 148 B | 133 B | 95.2 B | 90.3 B | 76.8 B | 69.5 B | 54.4 B | 48.8 B | 43.7 B | 39.3 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 193 B | 39.3 B | 109 B |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
45.8 B | $ 112.78 | 0.68 % | $ 34.3 B | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.13 | - | $ 4.89 M | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 16.31 | -0.12 % | $ 493 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 74.22 | -1.99 % | $ 5.01 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 457.05 | 0.03 % | $ 13.2 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Mettler-Toledo International
MTD
|
32.1 B | $ 1 242.53 | 0.28 % | $ 25.6 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.59 | -1.61 % | $ 425 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Pacific Biosciences of California
PACB
|
1.21 B | $ 1.37 | -1.8 % | $ 411 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Precipio
PRPO
|
10.9 M | $ 26.85 | -0.3 % | $ 34.8 M | ||
|
Personalis
PSNL
|
229 M | $ 7.51 | -1.38 % | $ 445 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
RadNet
RDNT
|
7.26 B | $ 59.53 | -3.58 % | $ 4.48 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 157.49 | -0.32 % | $ 7.81 B | ||
|
IQVIA Holdings
IQV
|
49.6 B | $ 164.98 | -1.19 % | $ 28.4 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 6.58 | -0.6 % | $ 275 M | ||
|
Sotera Health Company
SHC
|
7.07 B | $ 13.78 | -0.76 % | $ 3.91 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
34.1 M | $ 1.21 | -17.47 % | $ 6.59 M | ||
|
National Research Corporation
NRC
|
432 M | $ 17.47 | -0.26 % | $ 391 M | ||
|
Neuronetics
STIM
|
168 M | $ 1.54 | -4.06 % | $ 102 M | ||
|
Interpace Biosciences
IDXG
|
19.7 M | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
IDEXX Laboratories
IDXX
|
52.7 B | $ 572.18 | -1.09 % | $ 46 B | ||
|
Illumina
ILMN
|
15.3 B | $ 124.58 | 0.64 % | $ 19.8 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 99.8 | -0.55 % | $ 8.23 B | ||
|
Guardant Health
GH
|
15.2 B | $ 82.96 | -2.36 % | $ 10.4 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 44.3 | -0.45 % | $ 2.65 B | ||
|
Celcuity
CELC
|
506 M | $ 100.81 | -5.57 % | $ 3.98 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 263.8 | -0.23 % | $ 21.9 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 3.41 | -2.16 % | $ 1.83 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 7.9 | -2.47 % | $ 1.01 B | ||
|
Natera
NTRA
|
5.53 B | $ 194.02 | -3.03 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 17.35 | -1.2 % | $ 925 M | ||
|
OPKO Health
OPK
|
1.62 B | $ 1.14 | -1.3 % | $ 791 M |